These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 35672671)

  • 1. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
    BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
    Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
    BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
    Jacobsson S; Cole MJ; Spiteri G; Day M; Unemo M;
    BMC Infect Dis; 2021 Mar; 21(1):273. PubMed ID: 33736608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
    Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M;
    BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
    Cole MJ; Spiteri G; Chisholm SA; Hoffmann S; Ison CA; Unemo M; Van de Laar M
    Euro Surveill; 2014 Nov; 19(45):20955. PubMed ID: 25411689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.
    Riou J; Althaus CL; Allen H; Cole MJ; Grad YH; Heijne JCM; Unemo M; Low N
    BMC Infect Dis; 2023 Apr; 23(1):252. PubMed ID: 37081443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance.
    Cole MJ; Spiteri G; Jacobsson S; Pitt R; Grigorjev V; Unemo M;
    BMC Infect Dis; 2015 Aug; 15():321. PubMed ID: 26259560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe.
    Cole MJ; Spiteri G; Town K; Unemo M; Hoffmann S; Chisholm SA; Amato-Gauci AJ; van de Laar M; Ison CA;
    Sex Transm Dis; 2014 Dec; 41(12):723-9. PubMed ID: 25581808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of
    Blouin K; Lefebvre B; Trudelle A; Defay F; Perrault Sullivan G; Ezin Aloffan LND; Labbé AC
    BMJ Open; 2023 Aug; 13(8):e073849. PubMed ID: 37541749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study.
    Sánchez-Busó L; Cole MJ; Spiteri G; Day M; Jacobsson S; Golparian D; Sajedi N; Yeats CA; Abudahab K; Underwood A; Bluemel B; Aanensen DM; Unemo M;
    Lancet Microbe; 2022 Jun; 3(6):e452-e463. PubMed ID: 35659907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand.
    Nokchan N; Wongsurawat T; Jenjaroenpun P; Nitayanon P; Tribuddharat C
    PLoS One; 2022; 17(7):e0271657. PubMed ID: 35905043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance in
    Hernando Rovirola C; Spiteri G; Sabidó M; Montoliu A; Gonzalez V; Casabona J; Cole MJ; Noori T; Unemo M
    Sex Transm Infect; 2020 May; 96(3):204-210. PubMed ID: 32019895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
    Kovari H; de Melo Oliveira MD; Hauser P; Läuchli S; Meyer J; Weber R; Zbinden R
    BMC Infect Dis; 2013 Dec; 13():603. PubMed ID: 24369054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial-resistant Neisseria gonorrhoeae in Europe in 2020 compared with in 2013 and 2018: a retrospective genomic surveillance study.
    Golparian D; Cole MJ; Sánchez-Busó L; Day M; Jacobsson S; Uthayakumaran T; Abad R; Bercot B; Caugant DA; Heuer D; Jansen K; Pleininger S; Stefanelli P; Aanensen DM; Bluemel B; Unemo M;
    Lancet Microbe; 2024 May; 5(5):e478-e488. PubMed ID: 38614111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance profiles of Neisseria gonorrhoeae isolates in Vienna, Austria: a phenotypic and genetic characterization from 2013 to 2020.
    Geusau A; Chromy D; Heissenberger D; Lippert K; Eder C; Heger F; Indra A; Willinger B; Pleininger S
    Int J Antimicrob Agents; 2022; 60(5-6):106656. PubMed ID: 35988663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there an association between previous infection with
    Allen H; Merrick R; Ivanov Z; Pitt R; Mohammed H; Sinka K; Hughes G; Fifer H; Cole MJ
    Sex Transm Infect; 2023 Feb; 99(1):1-6. PubMed ID: 35246477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.